PHARMACIA AND UPJOHN FDA Approval NDA 017994

NDA 017994

PHARMACIA AND UPJOHN

FDA Drug Application

Application #017994

Documents

Letter2003-06-08
Label2003-06-08
Label2017-10-26
Letter2017-10-30

Application Sponsors

NDA 017994PHARMACIA AND UPJOHN

Marketing Status

Discontinued001

Application Products

001OINTMENT;TOPICAL0.05%0PSORCON EDIFLORASONE DIACETATE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1978-03-01STANDARD
LABELING; LabelingSUPPL2AP1978-11-07
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1979-12-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1979-05-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1979-07-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1979-07-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1979-07-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1981-01-16STANDARD
LABELING; LabelingSUPPL9AP1981-02-18
LABELING; LabelingSUPPL11AP1981-06-25
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1981-05-05STANDARD
LABELING; LabelingSUPPL13AP1982-08-20
LABELING; LabelingSUPPL14AP1982-08-20
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1983-11-04STANDARD
LABELING; LabelingSUPPL16AP1984-03-29
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1984-05-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1986-01-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1988-05-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1997-10-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1999-01-21STANDARD
LABELING; LabelingSUPPL22AP2003-05-30STANDARD
LABELING; LabelingSUPPL26AP2017-10-25STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL12Null0
SUPPL15Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL26Null15

CDER Filings

PFIZER
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 17994
            [companyName] => PFIZER
            [docInserts] => ["",""]
            [products] => [{"drugName":"PSORCON E","activeIngredients":"DIFLORASONE DIACETATE","strength":"0.05%","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"10\/25\/2017","submission":"SUPPL-26","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/017994s026lbl.pdf\"}]","notes":""},{"actionDate":"05\/30\/2003","submission":"SUPPL-22","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/17994slr022_psorcon_lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"PSORCON E","submission":"DIFLORASONE DIACETATE","actionType":"0.05%","submissionClassification":"OINTMENT;TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2017-10-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.